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Introduction
Staphylococcus aureus (S.aureus) bacterium is involved in a wide 
range of diseases such as skin infections, endocarditis, meningitis, 
osteomyelitis, bacteremia, and sepsis. Worldwide, an estimated 2 billion 
people carry some form of S.aureus; of these, up to 53 million (2.7% 
of carriers) are thought to carry Methicillin-resistant S.aureus (MRSA) 
[1]. Treatment for S.aureus infection encountered several roadblocks 
due to high level of Penicillin, Vancomycin and Methicillin resistance 
[2]. Hence, there is a requisite for developing new anti-staphylococcal 
agents. The enzymes DNA gyrase B and Methylthioadenosine / 
S-Adenosylhomocysteine Nucleosidase (MTAN) are present in 
bacteria and absent in humans thereby acting as a potential target in 
treating the S.aureus related diseases.
DNA gyrase is a type II topoisomerase that catalyzes the 
negative supercoiling of DNA in prokaryotes. It supercoils DNA 
through a process of strand breakage/resealing and DNA wrapping 
[3]. Its function is essential to DNA replication, transcription, and 
bacteriophage λ integrative recombination [4,5]. Its ability to negatively 
supercoil a relaxed plasmid DNA substrate is unique thus serving as a 
target for antimicrobial drugs. 
MTAN has recently been discovered and it is involved in the 
quorum sensing pathway of bacteria [6]. Inhibition of MTAN prevents 
the catalyzing mechanism needed to produce autoinducers which is 
necessary for the bacterial cells to sense the presence of its population. 
MTAN also catalyzes the irreversible cleavage of the glycosidic bond 
in 5’-methylthioadenosine (MTA) and S-adenosylhomocysteine 
(SAH) [7]. Inhibition of MTAN leads to aggregation of MTA and 
SAH substrates which in turn inhibits important biological processes 
in bacteria like polyamine synthesis, methylation, bacterial quorum 
sensing and methionine recycling [8]. Hence, the absence of MTAN 
enzyme in mammalian species and its essential role in bacteria has 
implicated this as a target for antimicrobial drug design [9,10].
Pyrazole and pyrazolones ring system plays an imperative role 
in wide range of biological activities such as antibacterial [11,12], 
antifungal [13], antimalarial [14], anticonvulsant, antitumor [15] 
and anti-inflammatory agents [16]. It is also interesting to note that 
pyrazoles are reported as well-known pharmacophores  in targeting 
many diseases and in specific a potent Cannabinoid inhibitors are 
designed using pyrazole scaffold [17- 20]. Several drug compounds such 
as Cyclooxygenase-2 (Cox-2) inhibitors [21], IL-1 synthesis inhibitors, 
and protein kinase inhibitors [22] have a 1(H)-phenyl pyrazole motif. 
Furthermore, few of the 1,5-diarylpyrazole derivatives have been used 
in combinatorial drugs which exhibit non-nucleoside HIV-1 reverse 
transcriptase inhibitory activities [23].  Here, in-silico studies were 
carried with pyrazole derivatives as possible inhibitors against DNA 
gyrase B and Nucleosidase of S.aureus. 
Material and Methods
Preparation of protein systems
X-ray crystal structures of DNA gyrase B (PDB ID: 3G7B) and 
5’-Methylthioadenosine/S-adenosylhomocysteine Nucleosidase [MTAN] 
(PDB ID: 3BL6) were retrieved from the Protein Data Bank [24]. The 
protein structures were prepared using the protein preparation wizard 
program from the Schrödinger suite in which water molecules (> 5Å 
radius) and small molecules present were removed from the structure. 
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Part of the preparation is that the bond orders were assigned, disulphide 
bonds were created and hydrogens were added to the PDB structures. 
Restrained impref minimization with default settings was performed on 
the structure with optimized potentials for liquid simulations (OPLS) 
2005 force field. The resulting structures were used for protein docking. 
Molecular docking
The compounds intended to be used for docking were prepared 
using default protocol of the Ligprep program [25] in the Schrödinger’s 
suite 9.3. Glide 5.8 program in the Schrödinger’s suite 9.3 was used 
for docking studies. Hierarchical series of filters to search for possible 
locations of the ligand in the active site region of the drug target is 
used by Glide (Grid based LIgand Docking with Energetics) [26,27]. 
Pyrazole compounds were docked to the target protein using the 
Induced Fit docking (IFD) protocol. G-score and E-model scores 
were used as ranking criteria for the best docked ligands. Initially, 30 
geometrically possible poses per compound were segregated and used 
for analysis. 
Molecular dynamics
Molecular dynamics (MD) simulations were performed using 
Desmond 3. 2 [28] incorporated into the Schrödinger suite 9.3 [29]. 
Each simulation was carried out for 5 nanoseconds (ns). The OPLS 
2005 [30] molecular mechanics force field is used for minimization 
and simulation. The pose with best E-model was considered for MD 
simulation studies. The complexes were solvated using the Desmond 
protocol resulting in a cubic box of 10 × 10 ×10 nm3. For the water 
molecules the simple point charge (SPC) model was used. The 
simulation was conducted at an ionic strength of 150 mM, which was 
obtained by adding sodium and chloride ions (gyrase system: 22 NaCl 
molecules; MTAN system: 26 NaCl molecules). Additional sodium ions 
were added to neutralize the systems (DNA gyrase system: 7 sodium 
ions; MTAN system: 10 sodium ions). Energy minimization of 1000 
steps using steepest descent was carried out to release the system from 
its conflicting contacts. The MD simulations were performed for i) 
DNA gyrase complex (30916 atoms) and ii) MTAN complex (28772 
atoms). SHAKE algorithm [31] was used to constrain the geometry 
of water molecules and hydrogen bonds. A cutoff of 9 Å was used for 
the short-range interactions. Electrostatic interactions were calculated 
using smooth particle mesh Ewald method [32]. Periodic boundary 
conditions were applied in x, y, and z directions. The NVT (constant 
number of atoms N, volume V and temperature T) ensemble was used 
for the simulations. Temperature was set to 300 K and regulated by the 
Noose Hover thermostat using a relaxation time of 1 pico second. A 
time step of 1.2 femto seconds was applied. Configurations were saved 
every 4.8 pico seconds. Root mean square displacement (RMSD) was 
calculated by fitting alpha carbons of the particular frame of interest 
with the structure from the first time frame. Trajectories were analyzed 
between 2 to 5 ns. 
Results and Discussion
The three dimensional x-ray structures of DNA gyrase B (PDB ID: 
3G7B) and MTAN (3BL6) of S.aureus, retrieved from the Protein Data 
Bank are shown in Figures 1 and 2 along with its active site residues. 
DNA gyrase B and MTAN were solved in complex with its respective 
inhibitors namely, Ciprofloxacin and Formycin A. These complex 
structures reveal essential interactions between the inhibitor and the 
protein and these interactions are taken as the reference for the pyrazole 
derivative that has been elucidated in our lab. The residues of DNA 
gyrase B such as Glu50, Asn54, Glu58 and Thr173 present in the ATP 
binding pocket are involved in ATPase activity [33]. The co-crystallized 
ligand are forms hydrogen bond interaction with the residues Asp81, 
Ser129 and Leu138 (Figure 1B) which are present within the ATP 
binding pocket.  The ligand is also further stabilized by a number of 
hydrophobic contacts with the residues Ile86, Pro87, Ile102, Leu103 
and the side chain of Arg86. 
Similarly the residues Glu11, Ser75, Glu173, Asp196 and Phe150 
frame the ribose binding site of MTAN. The co-crystallized ligand forms 
several hydrogen bonds with the residues of Ser75, Glu171, Glu173, 
Asp196 and polar backbone atoms of Ile151 and Met172. Phe150 forms 
Figure 1: A) DNA gyrase B of S.aureus. B) Binding pose of crystal 
structure ligand (3G7B).    C) Binding pose of Ciprofloxacin.
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base stacking interaction with the purine ring of the co-crystallized 
ligand which additionally contributes to the stability of the complex. 
Also the residues Asp196 and Glu11 are conserved among the MTAN 
of other bacterial species are thought to involve in substrate binding. 
The eight pyrazole derivatives shown in Figure 3 were taken for 
docking studies. These compounds are synthesized and their structures 
have been determined by X-ray crystallography [34-41]. The authors 
propose that these compounds could show inhibitory activity against 
DNA gyrase B and MTAN of S.aureus. The docking studies clearly 
reveal that some of these compounds bind efficiently to the enzymes of 
S.aureus. Glide E-model varies between -55 to -88 for compounds 1-8 
tested for DNA gyrase B and -56 to -120 for MTAN (Table 1). Out of 
the eight pyrazole derivatives analyzed, compound A and compound H 
forms the best interaction with DNA gyrase B and MTAN respectively.
Interaction of the best performing pyrazole derivative with 
DNA gyrase B 
The compound A has the highest Glide E-model score of -88.24. 
The oxygen atom forms hydrogen bond with the nitrogen atom of 
Arg84 (~3.1 Å) (Figure 4). Compound D having a Glide E-model score 
of -85.67, makes hydrogen bonds with the active site residue Thr173 
and Asp81 of DNA gyrase B (Figure 1, Supplementary material). The 
oxygen atom of compound D forms a hydrogen bond with the side 
chain carboxylate group of Asp81 (1.94 Å) (Figure 1, Supplementary 
material). Compound A and D have comparable Glide E-model scores 
(-88.24 vs. -85.67). Hydrogen bond pattern are different for these two 
compounds. Compound A forms a hydrogen bond to Arg84 (Figure 
4), whereas compound D forms hydrogen bonds with Gln58 and 
Asp81 (Figure 1, Supplementary material). Re-docking of the inhibitor 
from the co-crystallized complex structure (Figure 2, Supplementary 
material) of DNA gyrase B resulted in a Glide E-model score of -78.89 
which is comparable to the scores found for compound A and D (Table 
1). The re-docked conformation of co-crystallized ligand (Figure 2; 
Figure 2: A) MTAN of S.aureus B) Binding pose of crystal structure ligand 
(3BL6). C) Binding pose of Formycin.
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Figure 3: Schematic representation of structures of pyrazole derivatives. 
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Supplementary material) resembles the conformation of the pyrazole 
derivative (compound A and D respectively) 
We also analyzed the interaction and energy profile of DNA 
gyrase B with the already available drug Ciprofloxacin [29] (Figure 
3 (Supporting material)). The docking of Ciprofloxacin with DNA 
Gyrase B of S.aureus resulted in a Glide E-model score of -84.33, which 
is similar to the results found for compound A and D. The antibiotic 
showed a similar binding mode and interaction pattern as that of our 
pyrazole derivatives. 
Interaction of the best performing pyrazole derivative with 
MTAN 
The Compound F and H form the best interactions with MTAN 
of S.aureus. The Compound F form hydrogen bonds with Glu11, 
Ser75 and Arg192 of MTAN with the Glide E-model of -118.44. The 
compound F being small and compact binds deeper inside the active 
binding pocket of this enzyme with almost occupying the entire surface 
area of the pocket. The furan ring of the compound F forms π-π stacking 
interaction with the hydrophobic residue, Phe150 of MTAN. Apart from 
this, hydrophobic interactions are observed between the compound 
H - Phe206 and Compound H - Leu210 which also contributes to the 
stability of this complex. 
On the other hand the compound H being a very big hydrophobic 
compound could not make any hydrophilic interaction with the defined 
active site residues. The MTAN - Compound H complex is mostly 
stabilized by hydrophobic and van der Waals interactions resulting in 
a Glide E-model of -119.65. Though a part of the molecule went deep 
into the pocket, the entry of the other half of the molecule is blocked 
by the presence of bulky benzene ring in the structure as indicated in 
Figure 5 (Phe150 and Phe206). Although the compound H has polar 
atoms which can accept hydrogen bonds from the receptor molecule, 
the presence of bromo-benzene and two other phenyl rings in the 
Compound H structure blocked the full entry of the molecule deep into 
the active site. Benzene ring in compound H displays π-π stacking with 
Phe-150. This π-π stacking plays a vital role in providing stability to the 
Compound H - MTAN complex.
In order compare the binding mode of pyrazole derivative with the 
already established inhibitor for this enzyme, Formycin A, a transition 
state analog (Figure 3, Supplementary material) is taken for docking 
analysis along with pyrazole derivatives. The docking results showed 
that our compounds also bind with the MTAN of S.aureus in a similar 
way as like the Formycin A. (E-model -112.43).
Molecular dynamics simulation
Stability of DNA gyrase – compound A and MTAN – compound 
H complex were evaluated through 5 ns molecular dynamics (MD) 
Table 1: Glide E-model sores of the different compounds with DNA gyrase B and 
MTAN of S.aureus.
DNA gyrase B
Sl.No Compound Name Glide E-model
1 Compound A -88.24
2 Compound B -73.48
3 Compound C -63.14
4 Compound D -85.67
5 Compound E -55.82
6 Compound F -72.54
7 Compound G -72.28
8 Compound H -76.24
9 Co-crystallized ligand (PDB ID: 3G7B) -78.89
10 Ciproflaxin -84.33
MTAN
1 Compound A -93.30
2 Compound B -64.67
3 Compound C -67.73
4 Compound D -63.31
5 Compound E -56.56
6 Compound F -118.44
7 Compound G -81.67
8 Compound H -119.65
9 Co-crystallized ligand (Formycin A) (PDB ID: 3BL6) -112.43
Figure 4: Interaction of best the pyrazole derivative (compound A) with DNA 
gyrase B of S.aureus. 
Figure 5: Interaction of best pyrazole derivative (Compound H) with MTAN of 
S.aureus.
Citation: Jagadeesan G, Vijayakuma V, Palayam M, Suresh G, Krishnaswamy G, et al. (2015) Pyrazole Based Inhibitors against Enzymes of 
Staphylococcus aureus: A Computational Study. J Proteomics Bioinform 8: 142-148. doi:10.4172/jpb.1000362
Microarray Proteomics
Volume 8(7) 142-148 (2015) - 146 J Proteomics BioinformISSN: 1064-276X JPB, an open access journal 
Root mean square fluctuation (RMSF) is calculated for the DNA 
gyrase B – compound A and MTAN – compound H complexes. The 
RMSF is useful for characterizing local changes along the protein chain 
(Figure 7). Side chain fluctuations are observed within <3Å region. 
With few exceptions, remaining >95% of residues fluctuate within 
the region of 0.4 - 1.5 Å. In Figure 7 A, peaks with RMSF >1.2 Å are 
observed at region around Gly105, Met204 and Asn17. This is expected, 
since these residues are located in loop regions. In contrary, small peaks 
around the regions of Asn54 and Glu58 are observed indicating that 
there are considerable contacts during the simulation of DNA gyrase 
B. Glu58 maintains at least 2 contacts in the simulation (Figure 6A, 
Supplementary material). Glu58 maintains 52% of contacts throughout 
the simulation (Figure 6B, Supplementary material). Contacts between 
the compound and the residues Asn54 and Arg144 is established by 
water molecules (“water bridge”) at 33% and 35% respectively (Figure 
6B, Supplementary material). In the simulation on the MTAN – 
compound H complex, Glu11, Phe150 and Arg192 show respectively 
2-3, 2 and 1 contacts throughout the simulation. Other residues which 
simulations. Analysis was performed between 2 and 5ns. Root mean 
square displacement (RMSD) values of the DNA gyrase and MTAN Cα 
atoms and its respective ligands during the production phase relative 
to its starting structures are shown in Figure 6. Both complexes were 
stable, and RMSD of the Cα atoms in the proteins varied ~1Å, which is 
in the range commonly observed in protein simulations. The relatively 
large RMSD value for the compound is caused by the flipping of its 
benzyl ring at the start of the simulation to make π-π interactions 
with Phe206. The shift of ligand movement up to 4Å is due to the 
flipping of one benzene ring while the rest of the ligand remains in the 
initial position and is stabilized by hydrogen bonds. The neighboring 
interacting residues with compound A and H are shown in (Figure 4 
and 5) (Supplementary material). 
 
A
B
 
 
Figure 6: A) Root mean square displacement (RMSD) monitored during the 
simulation on 
A) DNA gyrase B - compound A complex and 
B) MTAN - compounds H complex. Protein and ligand RMSD are colored 
respectively blue and magenta. 
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Figure 7: Root mean square fluctuation (RMSF) extracted from the MD 
simulation on 
A) DNA gyrase B - compound A complex and 
B) MTAN - compounds H complex. 
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show good contacts over a long simulation period are Phe206, Leu210 
and Ile49 (Figure 7A, Supplementary material). Phe150 – compound 
H interactions are driven by π – π interactions. Phe150 interacts 52% 
and 34% of the simulation time with the benzene rings of compound H 
(Figure 7B, Supplementary material).
DNA gyrase – Compound A 
The docking and MD simulation observed the possible residues 
involved in binding of Compound A to DNA gyrase. The interacting 
residues which were observed during IFD docking were also found 
replicating the interactions during simulation (Figure 8). In the above 
plot, we can find the hydrogen bond interaction of Glu58 (32%) and 
Asn54 (1.2 %) with Compound A. Since water molecules are included 
in the simulations, we were able to obtain this interaction through 
water bridge Asn54 (20 %). The hydrophobic contacts of residues Arg86 
(21%), Ile102 (14 %) displayed during docking were also consistent 
throughout the simulation. The hydrogen bonds formed by Glu58 and 
Asn54 remained intact throughout the simulation (Figure 8A). We were 
able to observe that the residues Asn54, Gly85 and Arg144 displayed 
33%, 6%, and 35% contacts with the ligand during the simulation.
MTAN – Compound H
The residues Glu11 (90%), Ser75 (18%) and Arg192 (100%) 
of MTAN displayed consistent hydrogen bond interactions with 
compound H. Residues Ser195 (17%) and Ser75 (9%) interact with 
the compound via water bridges. The hydrophobic interactions which 
is calculated for residues Ile49 (51%), Phe150 (85%), Phe206 (52%) 
and Leu210 (43%) are within 3.6 Å. The hydrophobic interactions of 
Compound H contribute  the stability in the binding pocket is displayed 
by the π-π interaction of the benzene ring with residues Phe-150 and 
Phe-206 of MTAN. There are also some ionic interactions displayed 
by the residues Glu211 and Arg192 respectively. The residues Glu11, 
Phe150 and Arg192 maintain the contacts with the compound H at 
100%, 52% and 90% respectively during the entire simulation. 
Conclusion
MTAN important for the catalysis of irreversible cleavage 
of the glycosidic bond in 5’-methyladenosine (MTA) and 
S-adenosylhomocysteine (SAH) and DNA gyrase B important for 
the supercoiling of DNA during replication plays a vital role in the 
pathogenic bacterium S.aureus. Docking analysis of all the eight 
pyrazole derivatives, two drugs Ciprofloaxcin and Formycin A as well 
as MD simulations of the best ligands with the protein targets, DNA 
gyrase B and MTAN of S.aureus revealed important interactions 
between the derivatives and enzymes. The docking studies with the 
structure of pyrazole derivatives show that the compound A and F 
being small and compact molecule are located deep into the active 
site of the MTAN and DNA gyrase B of S.aureus. On the other hand, 
binding of the compound H to the active site of MTAN is prevented by 
the presence of bulky side chains causing steric clashes. 
In order to compare pyrazole derivatives for its efficiency standard 
drugs Ciprofloaxcin and Formycin A shown in Figure 1c and 2c is 
included in our docking studies. The above established enzyme-
inhibitor complex is taken as a model for explaining our pyrazole 
derivatives interaction with the active sites of the enzyme MTAN and 
DNA gyrase B of S.aureus. MD simulations of these best compounds 
(compound A- DNA Gyrase B and Compound H-MTAN) help us 
to understand the interactions of the protein- ligand complex in a 
better way. From our MD results we are able to describe water bridges 
observed with the residues of Arg-144 in DNA gyrase complex.
Through Molecular docking and dynamics studies, it was clear 
that among the eight pyrazole derivatives, the compound A, D, F and 
H shows better binding to DNA gyrase B and MTAN of S.aureus. 
The docking studies with the pyrazole derivatives showed that our 
derivatives also established a similar way of binding with the target 
protein which is explained by their comparable binding energy and 
interaction with the active site residues of the enzymes. To both of 
the target proteins, the phenol and the pyrazole ring plays a vital role 
in holding the molecule in place by forming hydrogen bond with the 
active site residues. Thus, the newly derived pyrazole derivatives show 
better mode of binding than the already available inhibitor and our 
finding will help in designing a novel anti-staphylococcal agents.
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